Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Status Completed

Clinical Trial Summary

Cluster-randomised trial comparing co-administration of Azithromycin/Ivermectin/Albendazole with separate administration of Azithromycin and Ivermectin/Albendazole. The study will be conducted in Beneshangul-Gumuz region, Ethiopia. Within this district, a study group of 8,000 people (in approximately 40 clusters) will receive the azithromycin, ivermectin & albendazole at a single time. A control group of 8,000 people (in approximately 40 clusters) within the same district will receive the current MDA treatment schedule beginning with Ivermectin/Albendazole followed two weeks later with azithromycin. All drug dosing will be in line with standard FMOH and WHO Guidelines for MDA for trachoma and lymphatic filariasis. The study will randomly sort subdistrict communities (Gotes) into the trial arm and the control arm. The study will compare the number of adverse events (AEs) and severe adverse events (SAEs) between the two arms to determine if co-administration is not inferior to the standard treatment. The primary outcome will be to demonstrate the safety of the triple-drug administration as measured by incidence of AEs/SAEs following the MDA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03570814
Study type	Interventional
Source	London School of Hygiene and Tropical Medicine
Contact
Status	Completed
Phase	Phase 4
Start date	December 1, 2021
Completion date	February 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03676140` - Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )	Phase 3
Completed	`NCT01949454` - Fluorometholone as Ancillary Therapy for TT Surgery	N/A
Completed	`NCT01202331` - Tripartite International Research for the Elimination of Trachoma	Phase 4
Completed	`NCT05634759` - Enhancing the A in SAFE for Trachoma	Phase 4
Recruiting	`NCT04185402` - Azithromycin Reduction to Reach Elimination of Trachoma	Phase 4
Active, not recruiting	`NCT00886015` - Modified Instrumentation for Surgery to Correct Trichiasis	Phase 3
Completed	`NCT00792922` - Partnership for Rapid Elimination of Trachoma	Phase 4
Completed	`NCT00522860` - A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery	Phase 4
Completed	`NCT00221364` - Trachoma Elimination Follow-up	Phase 4
Completed	`NCT00322972` - Trachoma Amelioration in Northern Amhara (TANA)	Phase 4
Withdrawn	`NCT00286026` - Azithromycin in Control of Trachoma II	Phase 4
Completed	`NCT00347763` - Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania	Phase 4
Terminated	`NCT04002726` - App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders	N/A
Terminated	`NCT03997487` - Smartphone App for Taking Images of Conjunctivae	N/A
Not yet recruiting	`NCT06289647` - Azithromycin Reduction to Reach Elimination of Trachoma B	Phase 4
Withdrawn	`NCT02655432` - Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population	Phase 0
Completed	`NCT01767506` - A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial	N/A
Completed	`NCT00618449` - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger	Phase 4
Completed	`NCT00356720` - Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma	Phase 3
Completed	`NCT03813069` - Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma	Phase 2